Cytrx Corp (CYTR)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Steven A. Kriegsman
Employees:
6
11726 SAN VICENTE BOULEVARD, SUITE 650, LOS ANGELES, CA 90049
310-826-5648

CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It provides clinical development of aldoxorubicin oncology pipeline for the treatment of cancer. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Data derived from most recent annual or quarterly report
Market Cap 21.341 Million Shares Outstanding38.801 Million Avg 30-day Volume 102.633 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.04
Price to Revenue0.0 Debt to Equity0.0 EBITDA-6.79 Million
Price to Book Value1.4609 Operating Margin0.0 Enterprise Value2.956 Million
Current Ratio4.118 EPS Growth0.136 Quick Ratio3.606
1 Yr BETA 0.5354 52-week High/Low / Profit Margin0.0
Operating Cash Flow Growth-7.376 Altman Z-Score-53.2111 Free Cash Flow to Firm -4.574 Million
View SEC Filings from CYTR instead.

View recent insider trading info

Funds Holding CYTR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CYTR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SNOWDY STEPHEN CHIEF EXECUTIVE OFFICER

  • Officer
0 2022-01-10 2

SIMPSON JENNIFER K.

  • Director
50,000 2021-12-15 3

BRIEN EARL W

  • Director
590,247 2020-08-14 0

KRIEGSMAN STEVEN A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
3,668,038 2020-08-07 0

IGNARRO LOUIS

  • Director
600,785 2020-08-07 0

CALDWELL JOEL K

  • Director
335,373 2020-08-07 0

CALOZ JOHN Y CHIEF FINANCIAL OFFICER

  • Officer
0 2019-12-13 0

CURTIS ERIC PRES., CHIEF OPERATING OFFICER

  • Officer
0 2018-05-03 0

KRATZ FELIX VICE PRESIDENT DRUG DISCOVERY

  • Officer
0 2017-12-15 0

CHAWLA SHANTA M.D. SENIOR VP-DRUG DEVELOPMENT

  • Officer
2,100 2017-06-13 0

RUBINFELD JOSEPH

  • Director
0 2016-12-15 0

LEVITT DANIEL J EVP AND CHIEF MEDICAL OFFICER

  • Officer
0 2016-12-15 0

WIELAND DOUGLAS SCOTT SR VP - DRUG DEVELOPMENT

  • Officer
0 2016-12-15 0

CHAWLA ANITA J

  • Director
0 2016-12-15 0

WARE OLIVIA C CHIEF COMMERCIAL OFFICER

  • Officer
0 2016-01-11 0

LEVIN BEN SVP-LEGAL AFFAIRS/GC/SECY

  • Officer
0 2015-12-15 0

COHEN CHERYL

  • Director
0 2015-12-15 0

SELTER ERIC JAY

  • Director
0 2015-12-15 0

WENNEKAMP RICHARD L.

  • Director
0 2014-12-15 0

LINK MAX

  • Director
0 2013-12-10 0

SELTER MARVIN R

  • Director
0 2013-12-10 0

PATTERSON SCOTT BRADFORD

  • 10% Owner
4,577,605 2013-12-10 0

GEYER DAVID SCOTT SR. V.P. OF MANUFACTURING

  • Officer
0 2011-12-12 0

BARBER JACK R CHIEF SCIENTIFIC OFFICER

  • Officer
0 2009-07-01 0

SHAH JAISIM SR. VP - BUSINESS DEVELOPMENT

  • Officer
0 2009-05-04 0

FOGELMAN MITCHELL K CHIEF FINANCIAL OFFICER

  • Officer
0 2008-11-21 0

NG SHI CHUNG SR VP RESEARCH & DEVELOPMENT

  • Officer
0 2008-11-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CYTRX CORP CYTR 2022-05-20 22:15:03 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 21:45:03 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 21:15:03 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 20:45:03 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 20:15:05 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 19:45:03 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 19:15:04 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 18:45:03 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 18:15:03 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 17:45:03 UTC -1.7092 2.5292 1600000
CYTRX CORP CYTR 2022-05-20 17:15:03 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 16:45:04 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 16:15:03 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 15:45:03 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 15:15:03 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 14:45:03 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 14:15:04 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 13:45:03 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 13:15:03 UTC -1.7092 2.5292 1200000
CYTRX CORP CYTR 2022-05-20 12:45:03 UTC -1.7092 2.5292 1200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments